SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.
SimBioSys has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
SimBioSys's investors include AV8 Ventures, Mayo Clinic, Genoa Ventures, Northpond Ventures, Heritage Group.
SimBioSys is headquartered in Chicago, United States.
SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.
SimBioSys is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SimBioSys — Funding & Investors." VCBacked, October 26, 2021, https://www.vcbacked.co/company/simbiosys. Accessed November 20, 2026.
VCBacked. (2021). SimBioSys — Funding & Investors. Retrieved November 20, 2026, from https://www.vcbacked.co/company/simbiosys
{{cite web |title=SimBioSys — Funding & Investors |url=https://www.vcbacked.co/company/simbiosys |website=VCBacked |access-date=November 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at SimBioSys? Request a listing update